press releases

Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients Paris, France and Manchester, UK, 19 May 2026: Yourgene Health (part of the Novacyt Group), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces the launch of Yourgene® Insight DPYD assay, an assay utilising genetic insights for safer chemotherapy treatments to align with up

Three-in-one system integrates large fragment analytics, DNA size selection and fluorometric quantification for long-read sequencing...

Offers expectant parents fully comprehensive prenatal screening test for genetic conditions, including microdeletions Manchester, UK, 13...

Offers clinicians and patients additional confidence in quality and accuracy of test for cystic fibrosis diagnosis Manchester, UK, 17...

Genetix will utilise Yourgene Health’s IONA Nx NIPT Workflow to deliver first NIPT service in region Service offers safe, fast and...

...Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries Yourgene’s LightBench instrument offers...

Yourgene Health installs first NIPT platform, the IONA test, in Morrocco, enabling Laboriad to offer safe, fast and accurate prenatal...

Offers clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and reagents for...

Workflows Following Prolonged Blood Storage in EDTA Tubes Extended EDTA blood tube storage offers improved flexibility and cost-saving in...